Details for New Drug Application (NDA): 204623
✉ Email this page to a colleague
The generic ingredient in PENNSAID is diclofenac sodium. There are forty-seven drug master file entries for this compound. One hundred and twenty-five suppliers are listed for this compound. Additional details are available on the diclofenac sodium profile page.
Summary for 204623
Tradename: | PENNSAID |
Applicant: | Horizon |
Ingredient: | diclofenac sodium |
Patents: | 19 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 204623
Mechanism of Action | Cyclooxygenase Inhibitors |
Physiological Effect | Decreased Prostaglandin Production |
Suppliers and Packaging for NDA: 204623
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PENNSAID | diclofenac sodium | SOLUTION;TOPICAL | 204623 | NDA AUTHORIZED GENERIC | Padagis US LLC | 0574-0167 | 0574-0167-12 | 1 BOTTLE in 1 CARTON (0574-0167-12) / 112 g in 1 BOTTLE |
PENNSAID | diclofenac sodium | SOLUTION;TOPICAL | 204623 | NDA AUTHORIZED GENERIC | Bryant Ranch Prepack | 63629-9603 | 63629-9603-1 | 1 BOTTLE in 1 CARTON (63629-9603-1) / 112 g in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;TOPICAL | Strength | 2% | ||||
Approval Date: | Jan 16, 2014 | TE: | AB | RLD: | Yes | ||||
Patent: | ⤷ Try a Trial | Patent Expiration: | Jul 10, 2029 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | USE OF TOPICAL DICLOFENAC ON THE KNEE AND A SECOND TOPICAL PRESCRIPTION MEDICATION ON THE SAME KNEE | ||||||||
Patent: | ⤷ Try a Trial | Patent Expiration: | Apr 21, 2028 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | USE OF TOPICAL DICLOFENAC ON A JOINT FOR TREATING OSTEOARTHRITIS | ||||||||
Patent: | ⤷ Try a Trial | Patent Expiration: | Aug 9, 2030 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | COMBINATION USE OF TOPICAL DICLOFENAC ON THE KNEE AND ADMINISTRATION OF AN ORAL NSAID. |
Complete Access Available with Subscription